Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha

Cristian Bellodi1, Karin Kindle, Francesca Bernassola

  • 1Medical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.

Insights

Mutant promyelocytic leukemia (PML) proteins disrupt retinoic acid (RA) signaling in acute promyelocytic leukemia (APL). These mutations stabilize the PML-RARalpha fusion protein, inhibiting crucial differentiation pathways and worsening patient prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The promyelocytic leukemia (PML) protein is a tumor suppressor crucial for regulating apoptosis and growth suppression.
  • In acute promyelocytic leukemia (APL), PML is aberrantly fused with retinoic acid receptor-alpha (RARalpha) due to chromosomal translocation.
  • Specific missense mutations in PML alleles lead to a truncated, cytoplasmic form (Mut PML), associated with retinoic acid resistance and poor prognosis in APL patients.

Purpose of the Study:

  • To investigate the role of Mut PML in the pathogenesis of APL.
  • To elucidate the molecular mechanisms by which Mut PML affects PML-RARalpha function and retinoic acid (RA) signaling.
  • To explore the significance of cytoplasmic localization of PML-RARalpha in APL transformation.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.
  • Immunofluorescence microscopy to visualize protein localization in PML-cytoplasmic bodies (PML-CBs).
  • Reporter gene assays to assess transcriptional activity.
  • Cell differentiation assays in response to retinoic acid (RA).

Main Results:

  • Mut PML localizes to cytoplasmic PML-CBs and interacts with PML-RARalpha within these bodies.
  • Mut PML potentiates PML-RARalpha-mediated inhibition of RA-dependent transcription.
  • Mut PML stabilizes PML-RARalpha, thereby inhibiting RA-induced differentiation and contributing to APL progression.
  • A cytoplasmically localized mutant of PML-RARalpha inhibits RA-dependent transcription and differentiation, suggesting a role in transformation.
  • The bcr3 PML-RARalpha isoform is predominantly cytoplasmic and localizes to PML-CBs.

Conclusions:

  • Mut PML plays a critical role in APL pathogenesis by interfering with RA signaling and promoting cellular transformation.
  • Cytoplasmic sequestration of PML-RARalpha, particularly in PML-CBs, is a key mechanism contributing to APL.
  • These findings offer novel molecular insights into APL development and suggest potential therapeutic targets.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.